These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Rationale for growth hormone therapy in children with chronic kidney disease.
    Author: Greenbaum LA, Del Rio M, Bamgbola F, Kaskel F.
    Journal: Adv Chronic Kidney Dis; 2004 Oct; 11(4):377-86. PubMed ID: 15492975.
    Abstract:
    Growth retardation is a common complication in children with chronic kidney disease. Treatable causes of growth retardation in these patients include renal osteodystrophy, metabolic acidosis, and inadequate nutritional intake. In addition, disturbances in the growth hormone-insulinlike growth factor I axis are a major cause of decreased growth. Administration of recombinant human growth hormone can overcome this problem, allowing catch-up growth and achievement of normal or improved adult height.
    [Abstract] [Full Text] [Related] [New Search]